Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Apixaban 5 mg vs Eliquis in Healthy Thai Volunteers (Fasting)
TCTR20220726004Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of apixaban (2 arms), sponsored by Bio-innova. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
apixaban
Beyond the preview
Go deeper on TCTR20220726004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220726004.